Search CROs

• Biostatistics & Statistical Programming
• Clinical Operations
• Data Management & eClinical

Strategy, research, clinical development, and transformation consulting for biopharma. Combines Putnam, Research Partnership, STEM, and Vynamic to deliver end-to-end expertise from pipeline to launch.

• Bioanalysis
• Clinical Imaging Core Lab
• Clinical Operations

Leading clinical research organization providing preclinical to late-phase imaging, randomization and trial supply management (RTSM), and eClinical services to the global biopharmaceutical industry.

• Biostatistics & Statistical Programming
• Cardiovascular & Metabolic Specialty Services
• Central Laboratory Services

Clario provides comprehensive clinical trial endpoint solutions spanning cardiac safety, eCOA, medical imaging, respiratory, and precision motion analysis, supporting approximately 70% of FDA and EMA novel drug approvals over the past decade.

• Biostatistics & Statistical Programming
• Clinical Operations
• Phase I Clinical Trials

YPrime delivers configurable eCOA, IRT, and eConsent clinical trial technology platforms with consulting services, supporting ~1,000 studies globally across 19+ therapeutic areas.

• Biostatistics & Statistical Programming
• Clinical Operations
• Phase I Clinical Trials

Clinical trial technology and services provider with 30 years of experience supporting thousands of trials and 25% of novel drug approvals (FDA/EMA, 2021–2024). Offers eClinical solutions, protocol guidance from 50+ in-house scientists and clinicians, and global operational scale.

• Clinical Operations
• Clinical Trial Services
• Medical Writing

Pharmacovigilance and safety services provider offering end-to-end operations, technology-driven solutions, and specialized expertise in vaccines, CGT/ATMP, pediatric medicines, and geriatric populations.

• Biostatistics & Statistical Programming
• Clinical Operations
• Phase I Clinical Trials

Global CRO and FSP provider with 25+ years of experience delivering integrated clinical research solutions across North America, Europe, LATAM, and APAC.

• Clinical Operations
• Phase I Clinical Trials
• Phase II Clinical Trials

Global, full-service CRO specializing in oncology and rare disease clinical development, with complementary pharmacovigilance and QA consulting brands.

• Biostatistics & Statistical Programming
• Cardiovascular & Metabolic Specialty Services
• Central Laboratory Services

ICON is a CRO with 8,000 biotech-dedicated professionals offering end-to-end clinical development, consulting, and therapeutic expertise across all development phases.

• Clinical Operations
• Clinical Trial Services

Clinical research organization pioneering integrated clinical trials at the point of care, connecting patients with trials and reducing drug development timelines.

• Biostatistics & Statistical Programming
• Cardiovascular & Metabolic Specialty Services
• Clinical Imaging Core Lab

Specialized CRO supporting clinical development in neuroscience and metabolic disease across all phases, with direct access to 20 wholly-owned US research sites and 400+ beds.

• Bioanalysis
• Biomarker Assays
• Biostatistics & Statistical Programming

Global CRO specializing in early-phase clinical research and bioanalytical sciences with 650+ beds across 30 countries and 50+ years of experience.

• Analytical Method Development & Validation
• Bioanalysis
• Bioinformatics & Data Science

Full-service CRO and CDMO with specialized competency centers in drug discovery, formulation development, GMP manufacturing, and bioanalytical services across Germany and France.

• Bioanalysis
• Biomarker Assays
• Biostatistics & Statistical Programming

Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making.

• Clinical Operations
• Phase II Clinical Trials
• Phase III Clinical Trials

Biopharmaceutical company developing immunomodulatory therapies for immune-mediated ocular and systemic diseases, with late-stage clinical candidates targeting dry eye disease, allergic conjunctivitis, and retinal conditions.

• Biostatistics & Statistical Programming
• Clinical Operations
• Phase I Clinical Trials

Full-service CRO with over 30 years of experience offering clinical trials, biostatistics, medical writing, and health economics services across all phases of development.

• Biostatistics & Statistical Programming
• Clinical Operations
• Phase I Clinical Trials

Integrated clinical research site organization operating 60+ sites across the U.S. and Europe, supporting trials that contributed to 61 FDA-approved products since 1986.

• Clinical Operations
• Phase I Clinical Trials
• Phase II Clinical Trials

World's largest independent, community-based clinical trial site network offering decentralized and mobile research services across diverse patient populations globally.